IL-21 gene polymorphism is associated with the prognosis of breast cancer in Chinese populations

Breast Cancer Research and Treatment

Volumn 137, Issue 3, 2013, Pages 893-901

  You, Yonghe ^a   Deng, Jieqiong ^a   Zheng, Jian ^a   Hu, Min ^b   Li, Na ^a   Wu, Hongchun ^a   Li, Wei ^a   Lu, Jiachun ^c   Zhou, Yifeng ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; IL 21; Polymorphism; Prognosis

Indexed keywords

INTERLEUKIN 21; LUCIFERASE; INTERLEUKIN DERIVATIVE; MESSENGER RNA;

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IL 21 GENE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; VALIDATION PROCESS; AGED; ASIAN; BLOOD; BREAST TUMOR; CANCER STAGING; CASE CONTROL STUDY; CHINA; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; T LYMPHOCYTE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKINS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; RNA, MESSENGER; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84879383042     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2401-1     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893-2917. doi: 10.1002/ijc.25516
2. Sariego J (2010) Breast cancer in the young patient. Am Surg 76(12):1397-1400
3. Standish LJ, Sweet ES, Novack J, Wenner CA, Bridge C, Nelson A, Martzen M, Torkelson C (2008) Breast cancer and the immune system. J Soc Integr Oncol 6(4):158-168
4. Sondergaard H, Skak K (2009) IL-21: roles in immunopathology and cancer therapy. Tissue Antigens 74(6):467-479. doi: 10.1111/j.1399-0039.2009.01382.x
5. Spolski R, Leonard WJ (2008) Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 26:57-79. doi: 10.1146/annurev.immunol.26.021607.090316
6. Kishida T, Asada H, Itokawa Y, Cui FD, Shin-Ya M, Gojo S, Yasutomi K, Ueda Y, Yamagishi H, Imanishi J, Mazda O (2003) Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol Ther 8(4):552-558
7. Ma HL, Whitters MJ, Konz RF, Senices M, Young DA, Grusby MJ, Collins M, Dunussi-Joannopoulos K (2003) IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J Immunol 171(2):608-615
8. Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ (2005) Synergy of IL-21 and IL-15 in regulating CD8 + T cell expansion and function. J Exp Med 201(1):139-148. doi: 10.1084/jem.20041057
9. Brady J, Hayakawa Y, Smyth MJ, Nutt SL (2004) IL-21 induces the functional maturation of murine NK cells. J Immunol 172(4):2048-2058
10. Di Carlo E, Comes A, Orengo AM, Rosso O, Meazza R, Musiani P, Colombo MP, Ferrini S (2004) IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice. J Immunol 172(3):1540-1547
11. Stolfi C, Pallone F, Macdonald TT, Monteleone G (2012) Interleukin-21 in cancer immunotherapy: friend or foe? Oncoimmunology 1(3):351-354. doi: 10.4161/onci.191222011ONCOIMM0106R
12. Jiang L, Deng J, Zhu X, Zheng J, You Y, Li N, Wu H, Lu J, Zhou Y (2012) CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res 14(4):R105. doi: 10.1186/bcr3225
13. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229-235. doi: 10.1007/s10549-006-9242-8
14. Jurinke C, Oeth P, van den Boom D (2004) MALDI-TOF mass spectrometry: a versatile tool for high-performance DNA analysis. Mol Biotechnol 26(2):147-164. doi: 10.1385/MB:26:2:147
15. Jiang L, Zhang C, Li Y, Yu X, Zheng J, Zou P, Bin X, Lu J, Zhou Y (2011) A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population. Breast Cancer Res Treat 126(2):487-495. doi: 10.1007/s10549-010-1094-6
16. Lehmann U, Kreipe H (2001) Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 25(4):409-418. doi: 10.1006/meth.2001.1263S1046-2023(01)91263-0
17. Zheng J, Jiang L, Zhang L, Yang L, Deng J, You Y, Li N, Wu H, Li W, Lu J, Zhou Y (2012) Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. Carcinogenesis. doi: 10.1093/carcin/bgs307
18. Habib T, Senadheera S, Weinberg K, Kaushansky K (2002) The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41(27):8725-8731
19. Leonard WJ, Spolski R (2005) Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 5(9):688-698. doi: 10.1038/nri1688
20. Kovanen PE, Leonard WJ (2004) Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 202:67-83. doi: 10.1111/j.0105-2896.2004.00203.x
21. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, Johnston J, Madden K, Xu W, West J, Schrader S, Burkhead S, Heipel M, Brandt C, Kuijper JL, Kramer J, Conklin D, Presnell SR, Berry J, Shiota F, Bort S, Hambly K, Mudri S, Clegg C, Moore M, Grant FJ, Lofton-Day C, Gilbert T, Rayond F, Ching A, Yao L, Smith D, Webster P, Whitmore T, Maurer M, Kaushansky K, Holly RD, Foster D (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408(6808):57-63. doi: 10.1038/35040504
22. Monteleone G, Caruso R, Fina D, Peluso I, Gioia V, Stolfi C, Fantini MC, Caprioli F, Tersigni R, Alessandroni L, MacDonald TT, Pallone F (2006) Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 55(12):1774-1780. doi: 10.1136/gut.2006.093187
23. Parrish-Novak J, Foster DC, Holly RD, Clegg CH (2002) Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J Leukoc Biol 72(5):856-863
24. Brandt K, Singh PB, Bulfone-Paus S, Ruckert R (2007) Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev 18(3-4):223-232. doi: 10.1016/j.cytogfr.2007.04.003
25. Moroz A, Eppolito C, Li Q, Tao J, Clegg CH, Shrikant PA (2004) IL-21 enhances and sustains CD8 + T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol 173(2):900-909
26. Sondergaard H, Frederiksen KS, Thygesen P, Galsgaard ED, Skak K, Kristjansen PE, Odum N, Kragh M (2007) Interleukin 21 therapy increases the density of tumor infiltrating CD8 + T cells and inhibits the growth of syngeneic tumors. Cancer Immunol Immunother 56(9):1417-1428. doi: 10.1007/s00262-007- 0285-4
27. Park YK, Shin DJ, Cho D, Kim SK, Lee JJ, Shin MG, Ryang DW, Lee JS, Park MH, Yoon JH, Jegal YJ (2012) Interleukin-21 increases direct cytotoxicity and IFN-gamma production of ex vivo expanded NK cells towards breast cancer cells. Anticancer Res 32(3):839-846
28. Pure E, Allison JP, Schreiber RD (2005) Breaking down the barriers to cancer immunotherapy. Nat Immunol 6(12):1207-1210. doi: 10.1038/ni1205-1207
29. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348(3):203-213. doi: 10.1056/NEJMoa020177348/3/203
30. Zheng J, Yu X, Jiang L, Xiao M, Bai B, Lu J, Zhou Y (2010) Association between the cytotoxic T-lymphocyte antigen 4 +49G>A polymorphism and cancer risk: a meta-analysis. BMC Cancer 10:522. doi: 10.1186/1471-2407-10-522
31. Kajitani K, Tanaka Y, Arihiro K, Kataoka T, Ohdan H (2012) Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells. Breast Cancer Res Treat 134(1):139-155. doi: 10.1007/s10549-011- 1944-x
32. Cullen SP, Martin SJ (2008) Mechanisms of granule-dependent killing. Cell Death Differ 15(2):251-262. doi: 10.1038/sj.cdd.4402244
33. Pardo J, Aguilo JI, Anel A, Martin P, Joeckel L, Borner C, Wallich R, Mullbacher A, Froelich CJ, Simon MM (2009) The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation. Microbes Infect 11(4):452-459. doi: 10.1016/j.micinf.2009.02.004
34. Ugai S, Shimozato O, Kawamura K, Wang YQ, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M (2003) Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts. Cancer Gene Ther 10(3):187-192. doi: 10.1038/sj.cgt.77005527700552
35. Ugai S, Shimozato O, Yu L, Wang YQ, Kawamura K, Yamamoto H, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M (2003) Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects. Cancer Gene Ther 10(10):771-778. doi: 10.1038/sj.cgt.77006307700630
36. Sawalha AH, Kaufman KM, Kelly JA, Adler AJ, Aberle T, Kilpatrick J, Wakeland EK, Li QZ, Wandstrat AE, Karp DR, James JA, Merrill JT, Lipsky P, Harley JB (2008) Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 67(4):458-461. doi: 10.1136/ard.2007.075424
37. Ding L, Wang S, Chen GM, Leng RX, Pan HF, Ye DQ (2012) A single nucleotide polymorphism of IL-21 gene is associated with systemic lupus erythematosus in a Chinese population. Inflammation. doi: 10.1007/s10753-012- 9497-7
38. Thompson SD, Sudman M, Ramos PS, Marion MC, Ryan M, Tsoras M, Weiler T, Wagner M, Keddache M, Haas JP, Mueller C, Prahalad S, Bohnsack J, Wise CA, Punaro M, Zhang D, Rose CD, Comeau ME, Divers J, Glass DN, Langefeld CD (2010) The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. Arthritis Rheum 62(11):3265-3276. doi: 10.1002/art.27688
39. Jia HY, Zhang ZG, Gu XJ, Guo T, Cui B, Ning G, Zhao YJ (2011) Association between interleukin 21 and Graves' disease. Genet Mol Res 10(4):3338-3346. doi: 10.4238/2011.October.31.6